- Published on
Infectious Disease and Microbiology – Nonpathogenic Entamoeba Species
Overview
Several Entamoeba species may colonize the human gastrointestinal tract without producing clinically significant disease. Important examples include Entamoeba coli, Entamoeba hartmanni, and Entamoeba polecki.
These organisms are generally considered nonpathogenic intestinal protozoa and should not be confused with Entamoeba histolytica, which causes invasive amebiasis.
Important Species
The principal species in this group include:
• Entamoeba coli
• Entamoeba hartmanni
• Entamoeba polecki
These species are usually detected incidentally during parasitologic stool examination.
Microbiologic Characteristics
These Entamoeba species are protozoa that may inhabit the human intestinal tract.
The most important microbiologic distinction is:
Nonpathogenic Entamoeba species ≠ Entamoeba histolytica
E. histolytica is capable of tissue invasion and may cause intestinal and extraintestinal amebiasis, whereas E. coli, E. hartmanni, and E. polecki generally do not cause invasive disease.
Epidemiology
These nonpathogenic Entamoeba species have a worldwide distribution.
They may be detected in individuals from many geographic regions, particularly where exposure to fecally contaminated food or water occurs.
Clinical Significance
Most individuals carrying these organisms are asymptomatic.
Therefore, finding one of these Entamoeba species in a stool specimen usually represents intestinal colonization rather than active disease.
Possible Diarrhea
Although these organisms are generally considered nonpathogenic, some experts have suggested that they may rarely be associated with diarrhea.
However, when diarrhea occurs in a patient carrying one of these organisms, other causes should generally be investigated before attributing the symptoms to the Entamoeba species.
Distinction from Entamoeba histolytica
This distinction is particularly important for examinations and clinical interpretation.
E. histolytica
→ Pathogenic
→ Causes amebic colitis/dysentery
→ Can invade intestinal tissue
→ May disseminate to the liver and cause amebic liver abscess
E. coli, E. hartmanni,
and
E. polecki
→ Generally nonpathogenic
→ Usually asymptomatic
→ Typically represent intestinal colonization
→ Usually require no treatment
Entamoeba coli
Entamoeba coli is a nonpathogenic intestinal amoeba.
Importantly, Entamoeba coli is a protozoan and is completely different from Escherichia coli, the Gram-negative bacterium commonly abbreviated E. coli.
This distinction is a frequent source of confusion.
Diagnosis
Diagnosis is based on parasitologic examination of stool specimens.
Microscopic examination can demonstrate trophozoites or cyst forms and help distinguish nonpathogenic Entamoeba species from pathogenic E. histolytica.
Accurate identification is important because treatment requirements differ substantially.
Treatment
For uncomplicated colonization with these nonpathogenic Entamoeba species:
No treatment is usually required.
Their presence alone is not an indication for antiparasitic therapy.
Additional Treatment
The source describes treatment for the unusual patient who has:
An Entamoeba species detected
- ●
Persistent diarrhea
- ●
No other identifiable cause
Possible regimens described include:
Metronidazole 500 mg orally every 8 hours for 6 days
or
Tinidazole 1 g orally every 12 hours for 3 days
Because these organisms are generally regarded as nonpathogenic, treatment should not automatically follow a positive stool finding.
High-Yield Clinical Pattern
Protozoan detected in stool
- ●
Identified as E. coli, E. hartmanni, or E. polecki
- ●
No invasive intestinal disease
→ Think nonpathogenic Entamoeba colonization
Exam Essentials
Genus: Entamoeba
Species: E. coli, E. hartmanni, E. polecki
Type: Protozoa
Distribution: Worldwide
Usual pathogenicity: Nonpathogenic
Typical clinical course: Asymptomatic
Possible association: Rare diarrhea, although causality is uncertain
Diagnosis: Parasitologic stool examination
Routine treatment: None required
Critical distinction: Do not confuse with Entamoeba histolytica
E. histolytica: Causes invasive amebiasis
Key clinical pearl: Entamoeba coli, E. hartmanni, and E. polecki are generally nonpathogenic intestinal protozoa, so their detection in stool usually does not require treatment; the crucial clinical task is distinguishing them from pathogenic E. histolytica.